Attacks of follow-up ezetimibe-statin products, leading 50% market growth
Follow-up products which entered the market after the patent expiration of ezetimibe, a hyperlipidemia therapy, last April, have quickly started to make performances.
Due the effect of the follow-up products, the ezetimibe-statin complex market grew approximately 50% up last May compared to the ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
